| Product Code: ETC9965516 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States continued to see significant import shipments of expectorants in 2024, with Canada, Mexico, UK, India, and China emerging as the top exporting countries. Despite the high concentration levels indicated by the HHI, the industry experienced steady growth with a CAGR of 4.82% from 2020 to 2024. However, there was a slight decline in growth rate from 2023 to 2024 at -0.59%, indicating potential shifts in the market dynamics. The diverse range of exporting countries reflects the global demand for expectorants in the US market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Expectorants Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Expectorants Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Expectorants Market - Industry Life Cycle |
3.4 United States (US) Expectorants Market - Porter's Five Forces |
3.5 United States (US) Expectorants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Expectorants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Expectorants Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 United States (US) Expectorants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma |
4.2.2 Growing awareness about the importance of respiratory health and self-care |
4.2.3 Rising geriatric population in the United States leading to higher demand for expectorants |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval and marketing |
4.3.2 Side effects associated with certain expectorant medications |
4.3.3 Competition from alternative therapies such as home remedies and natural remedies |
5 United States (US) Expectorants Market Trends |
6 United States (US) Expectorants Market, By Types |
6.1 United States (US) Expectorants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Expectorants Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Expectorants Market Revenues & Volume, By Drug, 2021- 2031F |
6.1.4 United States (US) Expectorants Market Revenues & Volume, By OTC, 2021- 2031F |
6.1.5 United States (US) Expectorants Market Revenues & Volume, By Herbal, 2021- 2031F |
6.1.6 United States (US) Expectorants Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Expectorants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Expectorants Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United States (US) Expectorants Market Revenues & Volume, By Inhalational, 2021- 2031F |
6.2.4 United States (US) Expectorants Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Expectorants Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Expectorants Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Expectorants Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United States (US) Expectorants Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 United States (US) Expectorants Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Expectorants Market Import-Export Trade Statistics |
7.1 United States (US) Expectorants Market Export to Major Countries |
7.2 United States (US) Expectorants Market Imports from Major Countries |
8 United States (US) Expectorants Market Key Performance Indicators |
8.1 Number of prescriptions for expectorants |
8.2 Patient adherence rates to expectorant therapy |
8.3 Rate of new product development and innovation in the expectorants market |
9 United States (US) Expectorants Market - Opportunity Assessment |
9.1 United States (US) Expectorants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Expectorants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Expectorants Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 United States (US) Expectorants Market - Competitive Landscape |
10.1 United States (US) Expectorants Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Expectorants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |